• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
  • Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Huddle up: Injury comparisons across sports

Huddle up: Injury comparisons across sports

by Truveta Research | Apr 27, 2023 | Research, Research Insights

While many adults engage in sports, even more children participate in sports (Blendon et al., 2015). A 2020 report suggests that over 50% of children between 6-17 have participated in sports within the last year (Black et al., 2022), which is an increase from under...
Double play: Multi-injury athletes, by the numbers

Double play: Multi-injury athletes, by the numbers

by Truveta Research | Apr 21, 2023 | Research, Research Insights

With over 3.5 million sport injuries estimated to occur each year (Johns Hopkins Medicine, 2023), we spent the last several weeks digging into and describing injury patterns related to specific sports: basketball, soccer, baseball/softball, and football. Although...
Red card: Soccer injuries by the numbers

Red card: Soccer injuries by the numbers

by Truveta Research | Mar 21, 2023 | Research, Research Insights

Today we continue our series of sports injury-related insights. Truveta Research first started looking at sports-related injuries following Damar Hamlin’s cardiac event during Monday Night Football on January 2, and after exploring in Truveta Studio, we shared that...

Share this


Recent posts

  • Evaluating recent trends in early measles vaccinations in Texas
  • Cancer innovation needs better data—not just better drugs
  • ISPOR 2025: Trends in the prescribing and dispensing of GLP-1 anti-obesity medications among adults with cardiovascular disease

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice